AUM$56.6M
Expense Ratio0.99%
NAV$35.59
Holdings44
InceptionNov 19, 2023
Price Chart
Key Statistics
Previous Close
$33.85Day Range
$33.64$34.05
52-Week Range
$26.25$36.63
Avg Volume
3.4KDividend Yield
1.36%Expense Ratio
0.99%AUM
$56.6MShares Outstanding
1.6MSector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 100.00% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 75.41% |
| Switzerland | 8.59% |
| United Kingdom | 4.67% |
| Denmark | 4.01% |
| Ireland | 2.25% |
| Japan | 1.91% |
| Israel | 1.77% |
| Other | 0.70% |
| Canada | 0.70% |
Fund Information
- Issuer
- Tema
- Category
- Healthcare
- Types
- Biotech
- Inception Date
- Nov 19, 2023
- Exchange
- NASDAQ
- Description
- The Tema Heart & Health ETF (HRTS) seeks to invest in companies that potentially stand to benefit from further advances in biotechnology and healthcare, specifically companies involved in cardiology, metabolic diseases and weight loss therapies.
Similar ETFs
The Tema Cardiovascular and Metabolic ETF (HRTS) is an exchange-traded fund issued by Tema that launched on Nov 19, 2023. It currently manages $56.6M in assets under management. The fund charges an expense ratio of 0.99%. The fund holds 44 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 47.2% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | LLY | ELI LILLY & CO | 9.95% | 5,263 | $5.3M |
| 2 | RHHBY | ROCHE HOLDING AG | 5.12% | 50,740 | $2.7M |
| 3 | JNJ | JOHNSON & JOHNSON | 4.72% | 10,273 | $2.5M |
| 4 | AZN.L | ASTRAZENECA PLC | 4.67% | 12,706 | $2.5M |
| 5 | MRK | MERCK & CO INC | 4.16% | 18,918 | $2.2M |
| 6 | TMO | THERMO FISHER SCIENTIFIC INC | 3.97% | 4,239 | $2.1M |
| 7 | UNH | UNITEDHEALTH GROUP INC | 3.91% | 7,253 | $2.1M |
| 8 | GILD | GILEAD SCIENCES INC | 3.71% | 13,435 | $2.0M |
| 9 | VRTX | VERTEX PHARMACEUTICALS INC | 3.48% | 3,737 | $1.8M |
| 10 | NOVN.SW | NOVARTIS AG | 3.46% | 11,781 | $1.8M |
| 11 | ABT | ABBOTT LABORATORIES | 3.34% | 16,017 | $1.8M |
| 12 | ABBV | ABBVIE INC | 3.03% | 7,045 | $1.6M |
| 13 | DHR | DANAHER CORP | 2.83% | 7,657 | $1.5M |
| 14 | BBIO | BRIDGEBIO PHARMA INC | 2.78% | 20,595 | $1.5M |
| 15 | NOVO-B.CO | NOVO NORDISK A/S | 2.31% | 31,589 | $1.2M |
Detailed Returns
| Period | Return | ETF | Cat. Avg | vs Avg |
|---|---|---|---|---|
| 1D | -0.27% | — | ||
| 1W | -1.38% | — | ||
| 1M | -4.66% | — | ||
| 3M | -4.08% | — | ||
| 6M | +12.27% | — | ||
| YTD | -3.77% | — | ||
| 1Y | +13.90% | — | ||
| 3Y | +27.14% | — | ||
| 5Y | +27.14% | — |
Moving Averages
20-Day MA
$35.45
Below 20-Day MA50-Day MA
$35.66
Below 50-Day MA200-Day MA
$31.73
Above 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$36.63
Current Price
$33.76
52-Week Low
$26.25
$26.25$36.63
Current Yield
1.36%
Annual Dividend
$0.9422
Frequency
1x/year
Last Ex-Date
Dec 10, 2025
Dividend History
| Ex-Date | Amount | Pay Date |
|---|---|---|
| Dec 10, 2025 | $0.4729 | Dec 11, 2025 |
| Dec 11, 2024 | $0.4693 | Dec 12, 2024 |
Dividend Payments Over Time
Category Comparison
| Metric | HRTS | Healthcare(223 ETFs) | Biotech(41 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.99% | 0.60% | 0.83% |
| AUM | $56.6M | $1.24B | $1.51B |
| Dividend Yield | 1.36% | 2.75% | 2.14% |
| Avg Volume | 3.4K | 800.9K | 1.3M |
| Holdings | 44 | 171 | 66 |
| Performance | |||
| 1-Month Return | -4.11% | -4.57% | -3.93% |
| 6-Month Return | +11.17% | +4.90% | +15.68% |
| YTD Return | -4.08% | -1.70% | -2.78% |
| 1-Year Return | +14.78% | +15.18% | +25.33% |
Compare with Another ETF
Search for an ETF to compare with HRTS: